Uncoupling Protein 2 (UCP2) and p53 Expression in Invasive Ductal Carcinoma of Breast
¿ø±Ô¿¬, ±è±³¿µ, ±èÀ±È, ÀÓ¼ºÁ÷, ¼ÛÁ¤À±,
¼Ò¼Ó »ó¼¼Á¤º¸
¿ø±Ô¿¬ ( Won Kyu-Yeoun )
°æÈñ´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
±è±³¿µ ( Kim Gou-Young )
°æÈñ´ëÇб³ µ¿¼½ÅÀÇÇк´¿ø º´¸®ÇаúÇб³½Ç
±èÀ±È ( Kim Youn-Hwa )
°æÈñ´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
ÀÓ¼ºÁ÷ ( Lim Sung-Jig )
°æÈñ´ëÇб³ µ¿¼½ÅÀÇÇк´¿ø º´¸®ÇаúÇб³½Ç
¼ÛÁ¤À± ( Song Jeong-Yoon )
°æÈñ´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
KMID : 0357920100440060565
Abstract
Background : Uncoupling protein 2 (UCP2) is a recently identified mitochondrial inner membrane anion carrier and a negative regulator of reactive oxygen species production. In this study, we evaluated the characteristics and relationships of UCP2 and p53 expression in breast cancer tissues.
Methods : Tissue microarray slides from 107 cases of invasive ductal carcinoma of the breast were constructed, UCP2 and p53 immunohistochemical staining was conducted, and clinicopathological correlations were investigated.
Results : UCP2 expression in invasive ductal carcinoma was high in 53 cases (49.5%), while p53 expression in invasive ductal carcinoma was high in 37 cases (34.6%). UCP2 expression was correlated significantly with histological grade (p = 0.038) and mitotic count (p = 0.050). UCP2 expression was correlated significantly with p53 expression in invasive ductal carcinoma of the breast (p = 0.045). UCP2 expression (p = 0.8308) and p53 expression (p = 0.3292) showed no significant difference for the overall survival rate in patients with invasive ductal carcinoma.
Conclusions : UCP2 expression in invasive ductal carcinoma increased proportionally with histological grade and mitotic count. High UCP2 expression in invasive ductal carcinoma was observed in conjunction with high p53 expression.
Å°¿öµå
Carcinoma; ductal; breast; Mitochondrial uncoupling protein 2; Tumor suppressor protein p53; Reactive oxygen species
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸